Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Watch CBS News
The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer’s disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
© 2024 LSD News title="Jegtheme">Jegtheme.